Dr. Liggett studies the molecular and genetic basis of signaling by G-protein coupled receptors, which represent the targets for about half of all prescribed drugs. He holds 15 patents and has over 25 years of continuous funding from the National Institutes of Health for studying genomics and receptors as they relate to heart and lung disease.